Huntington (HBAN) director converts deferred comp to 2 holdings
Rhea-AI Filing Summary
Ann B. Crane, a director of Huntington Bancshares Inc. (HBAN), reported purchases on 10/01/2025 under a director deferred compensation plan and directly. She acquired 1,268.493 shares directly and 847.672 shares indirectly at a reported price of $0.0000 (plan conversion). Following these transactions she beneficially owns 220,838.326 shares directly and 94,883.966 shares indirectly. The filing includes an exhibit: Exhibit 24 (Substitute Power of Attorney) and is signed by an attorney-in-fact on 10/03/2025. The filer clarifies the statement is not an admission of beneficial ownership for purposes of Section 16.
Positive
- Director increased direct holdings by 1,268.493 shares
- Director increased indirect holdings by 847.672 shares
- Beneficial ownership totals disclosed: 220,838.326 direct and 94,883.966 indirect shares
Negative
- None.
Insights
Director received shares via deferred compensation and holds sizable direct and indirect positions.
The Form 4 shows a director-level acquisition on 10/01/2025 with 1,268.493 shares acquired directly and 847.672 shares acquired indirectly under a director deferred compensation plan. This filing documents the director's increased economic stake and updates beneficial ownership totals to 220,838.326 direct and 94,883.966 indirect shares.
This is routine Section 16 reporting of compensation-related share conversion rather than an open-market purchase; it affects disclosure of insider holdings but does not by itself indicate a change in company control.
Shares were issued via a director deferred compensation mechanism at a reported price of $0.0000.
The transactions are coded as acquisitions with a transaction price of $0.0000, indicating conversion from deferred compensation rather than cash purchase. The report includes both direct (D) and indirect (I) ownership forms, reflecting personal ownership and plan-based holdings.
Exhibit disclosure includes a substitute power of attorney, and the form is executed by an attorney-in-fact on 10/03/2025.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 1,268.493 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 847.672 | $0.00 | $0.00 |
Footnotes (1)
- F1. The filing of this statement shall not be construed as an admission that the undersigned is, for the purpose of Section 16 of the Securities and Exchange Act of 1934 or otherwise, the beneficial owner of the securities.
AI-generated analysis. How Rhea-AI works. Not financial advice.